Pharming N.V.(PHAR) - 2023 Q4 - Earnings Call Presentation

Pediatric study for 1 to 6 years ongoing First patient dosed November 2023, enrollment continuing as planned 1. Rao VK and Oliveria JB. How I treat autoimmune lymphoproliferative syndrome. Blood 2011; 118(22):5741-51 2. Westerman-Clark et al 2021; Schwab C, Gabrysch A, Olbrich P, Patiño V, Warnatz K, et al. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects. J Allergy Clin Immunol. 2018;142(6):1932-1946 3. Eissing M, Ripken L, Schreibelt G, Westdorp H, Ligtenb ...